[Elsevier] Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial |
|
This post will be closed automatically in 2026-06-12 12:59
Reward10points
|
10
International joint ventures and internal technology transfer vs. external technology spillovers: Evidence from China
10
Developing an explainable Deep Neural Network for stress detection using biosignals and human-engineered features
10
Quantitative analysis of the U.S. chip embargo and China＊s export controls on GaGe and graphite
10
Effects of acceptance and commitment therapy-based intervention on fatigue interference and health-related quality of life in patients with advanced lung cancer: A randomised controlled trial
10
The influence of positive and negative intraoperative feedback in laparoscopic simulation in pediatric urology training
